Finally, recurrent pyoderma gangrenosum treated with Adalimumab: case report and review of the literature

J Eur Acad Dermatol Venereol. 2015 Jun;29(6):1245-7. doi: 10.1111/jdv.12703. Epub 2014 Sep 8.

Authors

A Campanati¹, V Brisigotti¹, G Ganzetti¹, E Molinelli¹, K Giuliodori¹, V Consales¹, S Racchini², E Bendia³, A Offidani¹

Affiliations

¹ Dermatological Unit, Department of Clinical and Molecular Sciences, Polytechnic University of the Marche Region, Ancona, Italy.
² Institute of Pathological Anatomy and Histopathology, Polytechnic University of the Marche Region, Ancona, Italy.
³ Department of Gastroenterology, Polytechnic University of the Marche Region, Ancona, Italy.

PMID: 25200926
DOI: 10.1111/jdv.12703

No abstract available

Publication types

Case Reports
Letter
Review

MeSH terms

Adalimumab / therapeutic use*
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Crohn Disease / complications
Crohn Disease / drug therapy
Female
Humans
Middle Aged
Pyoderma Gangrenosum / complications
Pyoderma Gangrenosum / drug therapy*
Recurrence
Retreatment

Substances

Anti-Inflammatory Agents, Non-Steroidal
Adalimumab